Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer [Phase 3]
The BEATRICE Phase 3 trial evaluating bevacizumab as adjuvant therapy in triple-negative breast cancer has completed, and results have been …
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial assessing standard chemotherapy with or without BSI-201 (iniparib) for triple-negative metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial assessing safety and effects of gefitinib in patients with EGFR-positive triple-negative metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating cetuximab in combination with cisplatin for triple-negative metastatic breast cancer has completed, with results …
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer [Phase 2]
A Phase II trial evaluating gemcitabine plus oxaliplatin for triple-negative metastatic breast cancer was terminated, with results posted in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients [Phase 2]
A Phase 2 study evaluating dasatinib in locally advanced triple-negative breast cancer was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer [Phase 2]
A randomized Phase II trial evaluating ixabepilone alone versus ixabepilone plus cetuximab as first-line therapy for women with triple-negat…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Trial of RAD001 in Triple Negative Metastatic Breast Cancer [Phase 2]
A Phase 2 trial of RAD001 (everolimus) in triple-negative metastatic breast cancer was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial [Phase 2]
This document summarizes a Phase 2 prospective trial evaluating salvage chemotherapy with Vinorelbine plus Oxaliplatin for metastatic triple…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients [Phase 2]
This document notes the completion of a Phase 2 trial of EndoTAG-1 in patients with triple-negative breast cancer. The study sponsor is Medi…
-
CLINICAL_TRIALS trial_result · 2011-11-16Clinical Trial Update: Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer [Phase 2]
This is a Phase 2 neoadjuvant trial evaluating a paclitaxel plus carboplatin and epirubicin regimen in triple-negative breast cancer. The tr…
-
CLINICAL_TRIALS trial_result · 2011-07-04Clinical Trial Update: Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC [Phase 2]
A Phase 2 trial evaluating gemcitabine and cisplatin as first-line therapy for triple-negative metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer [Phase 2]
Pfizer conducted a Phase 2 trial comparing SU011248 to standard chemotherapy in patients with previously treated triple-negative breast canc…
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients
This clinical trial update discusses the efficacy and safety of neoadjuvant chemotherapy in locally advanced triple-negative breast cancer. …